UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ----------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 4, 2004 ARCH CHEMICALS, INC. (Exact name of registrant as specified in its charter) Virginia 1-14601 06-1526315 (State or other (Commission File Number) (IRS Employer jurisdiction Identification of incorporation) Number) 501 Merritt 7, Norwalk, CT 06851 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (203) 229-2900 (N/A) (Former name or former address, if changed since last report) Item 5. Other Events. On March 4, 2004, Arch Chemicals, Inc. announced that it has signed a definitive agreement to acquire Avecia Limited's Biocides business. A copy of the press release is attached as Exhibit 99.1 to this report. Item 7. Exhibits. Exhibit No. Description - ----------- ----------- 99.1 Press Release of the Registrant dated March 4, 2004. 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 4, 2004 ARCH CHEMICALS, INC. By: /s/ Louis S. Massimo ----------------------------------- Name: Louis S. Massimo Title: Executive Vice President and Chief Financial Officer 3 EXHIBIT INDEX Exhibit No. Description - ----------- ----------- 99.1 Press Release of the Registrant dated March 4, 2004. 4